Delivery Order SPE2DR25D2212-SPE2DR26FB9UP
Award Date 2/4/26
Potential Completion Date 2/5/26
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,083.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine on January 6, 2026, with completion expected by January 7, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of ENGERIX-B 20 MCG/ML vaccine at a firm fixed price of $1,727.74. This non-set-aside delivery order, which is expected to be completed by January 8, 2026, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,970.41 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply, with a completion date of December 30, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.75 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine (20 micrograms per milliliter syringes). This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,438.30 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract was awarded on January 23, 2026, with an ultimate completion date of January 26, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a firm fixed-price, competitively awarded transaction with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for ENGERIX-B 20 MCG/ML vaccine supply, with a ceiling value of $1,751.90 and an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The award carries no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,555.46 to Amerisourcebergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine, with a completion date of January 8, 2026. This is a firm fixed-price, non-set-aside contract executed on January 7, 2026, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is a subsidiary of parent...
- The Defense Logistics Agency awarded a delivery order valued at $23,145.08 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine product, valued at $3,878.46 with a firm fixed price contract type. The award was issued on December 10, 2025, with an ultimate completion date of December 11, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply, valued at $18,567.90 under a firm fixed price structure. This non-set-aside award was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...